Institutional investors hold a majority ownership of ZTS through the 90.35% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2016, these large investors purchased a net $17.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRINCIPAL MANAGEMENT CORP. Bought 202.7 Thousand shares of Zoetis Inc